Myocardial Infarction Flashcards

1
Q

What is a myocardial infarction?

A

Rapid development of myocardial necrosis due to a critical imbalance between oxygen supply & myocardial
demand.

• Also known as a Heart attack.
• The most important form of IHD.
• One of the major cause of mortality around the world.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical symptoms of MI

A
  • May or may not present with angina pectoris.
  • Dyspnoea • due to pulmonary congestion caused by impaired
    contractility
  • Diaphoresis(profuse sweating).
  • Rapid, weak pulse.
  • Anxiety.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of MI and factors responsible

A

The primary cause for Ml is CORONARY ARTERY OCCLUSION.
• Factors responsible are:
- Coronary atherosclerosis
- Vasospasm
• Platelet aggregation
• Cocaine abuse.
- Emboli
• AF
• Lt. sided mural thrombus
• Vegetations of inf. endocarditis

Ischemia without detectable CA & thrombosis
• Vasculitis of intramural vessels
• Sickle cell disease
• Amyloidosis
• Vascular dissection
• Low systemic BP(shock)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cardiac markers for MI

A

• Enzymes
- Creatine kinase(MB fraction)
- Aspartate transaminase(AST)
- Lactate dehydrogenase
• Non-enzyme proteins
- Troponin T & 1
- Myoglobin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

WHO DIAGNOSIS OF MI

A

Requires atleast 2 of the following criteriae:
- Prolonged ischemic-type chest discomfort.
- Serial ECG changes.
- Elevation of cardiac markers in serum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TREATMENT: Initial treatment

A

1.Morphine (2.5-5.0 mg i.v) - For sudden relief of pain
& anxiety.

  1. Aspirin (162-325 mg orally) - For prevention of
    thrombus extension, embolism, venous thrombosis.
  2. O2 inhalation & assisted respiration, if needed.

4.I.V fluids - Maintain blood volume & perfusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment: Subsequent Management

A
  • Treatment of complications:
    •Arrhythmias
    •Pump failure
    •Thromboembolism
    •Acidosis - NaHCO, i.v infusion
  • Secondary prevention of further consequences
    & future MI.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Prevention & Treatment of Arrhythmia

A
  1. B-blocker
    - Prophylactic i.v infusion
    • Inj. Atenolol(50 mg)
    - oral administration for few days
    • Tab. Atenolol(50 mg)
    - Reduce incidence of arrhythmia & mortality
    Note: ß-blockers used early in evolving Mi can reduce the infarct
    size & subsequent complications
  2. Other Antiarrhythmics
    - Lidocaine, Procainamide for tachyarrhythmia
    Note: Bradycardia & Heart block may be managed with
    Atropine or electrical pacing.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prevention & Treatment of Arrhythmia

A
  1. B-blocker
    - Prophylactic i.v infusion
    • Inj. Atenolol(50 mg)
    - oral administration for few days
    • Tab. Atenolol(50 mg)
    - Reduce incidence of arrhythmia & mortality
    Note: ß-blockers used early in evolving Mi can reduce the infarct
    size & subsequent complications
  2. Other Antiarrhythmics
    - Lidocaine, Procainamide for tachyarrhythmia
    Note: Bradycardia & Heart block may be managed with
    Atropine or electrical pacing.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pump Failure

A
  • The objective is to G.O and/or filling pressure without
    unduly increasing cardiac work or reducing B.P.
  • The drugs include:
    • Furosemide: Reduce preload & pulm. edema.
    • Vasodilators:
    -GTN, Sod. Nitroprusside
  • Reduce venous return.
    dardiac work load.
    • Inotropic agents:
    -Dopamine, Dobutamine
    -Augment the pumping action of heart.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Thrombolysis & Reperfusion

A
  • First infarct patient • Inj. Streptokinase - 15,00,000 units i.v infusion over 1
    hour.
  • Subsequent infarcts
    • Recombinant tissue plasminogen activator(Alteplase). • Regimen for coronary thrombolysis is 15 mg i.v followed by 0.75 mg/kg over 30 min, & 0.5mg/kg over
    following hour:
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fibrinolytics

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Adverse reactions to fibrinolytics

A

• Bleeding
• Nausea, vomiting
• Multiple micro emboli • Allergic reactions - Streptokinase is
antigenic - cause anaphylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fibeinolytics

A

Thrombolysis & Reperfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Contraindications to fibrinolytics

A

:
• Haemorrhagic diathesis
• Pregnancy
• Recent symptoms of peptic ulcer / GI
bleeding
• Recent stroke (Previous 3 mths)
• Recent surgery (Previous 10-14 days)
• Proliferative Diabetic retinopathy
• Severe uncontrolled hypertension
• Aortic dissection
• Acute pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Long term Treatment

A

The objectives include:
• Prevention of remodeling & subsequent CHF. - ACE inhibitors / ARBs are of proven efficacy & afford
long term survival benefit.
• Prevention of future attacks.
- Platelet inhibitors: - Aspirin or Clopidogrel given on long term basis are
routinely prescribed.

  • B blockers:
  • Reduces risk of reinfarction, CHF & mortality
  • Given for at least 2 years unless contraindicated
  • Control of hyperlipidemia
  • Hypolipidemic drugs, especially statins.
  • Dietary substitution with unsaturated fats.